MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$5,305K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income (loss)
Maturities of available-for-sale...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Deferred income tax (benefit) ex...
Purchases of available-for-sale ...
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
45,104
1,186
11,070
621
Impairment of intangible assets
-
-
0
-
Impairment of long-lived assets
-
-
0
-
Gain on settlement of global cooling escrow
-
-
0
-
Depreciation
411
374
261
636
Amortization of intangible assets
398
325
325
699
Amortization of loan costs
-
-
0
-
Stock-based compensation
3,854
4,806
7,077
5,904
Non-cash lease expense
1,849
-188
-118
1,323
Deferred income tax (benefit) expense
-42,431
9
0
14
Change in fair value of contingent consideration
-
-
0
-
Change in fair value of equity investment and other
-
-
942
41
Accretion of available-for-sale investments
75
122
201
230
Loss on disposal of property and equipment, net
-
-
-11
0
Gain on disposal of assets held for rent, net
0
0
0
-167
Ipr&d expense
0
-
0
0
Loss on disposal of global cooling
-
-
-
0
Net gain on disposal of subsidiaries
-
-
10,324
-
Accounts receivable, trade, net
-2,405
5,104
-1,938
782
Inventories
2,757
2,679
2,331
197
Prepaid expenses and other assets
246
-3,218
462
3,000
Accounts payable
-1,370
2,206
-952
-679
Accrued expenses and other current liabilities
-755
-4,400
680
1,564
Sales taxes payable
-39
-148
-1,385
105
Warranty liability
-
-
5
-
Other
0
26
264
0
Net cash provided by operating activities
6,348
-491
4,916
6,104
Purchases of available-for-sale securities
14,925
20,430
36,670
13,090
Proceeds from sale of available-for-sale securities
2,359
2,331
3,238
1,836
Maturities of available-for-sale securities
12,150
16,436
15,412
10,962
Purchases of assets held for rent
0
0
101
373
Purchases of property and equipment
1,043
167
4,258
5,220
Investment in ipr&d
0
-
0
0
Investment in convertible promissory note
-
-
0
2,000
Proceeds from sale of divested entities
-
-
23,516
-
Payments on divestiture of global cooling
-
-
0
0
Purchase of intangible assets
120
-
0
-
Net cash used in investing activities
-1,579
-1,830
1,137
-5,967
Payments on equipment loans
-
-
0
0
Issuance of common stock
-
-
0
-
Proceeds from exercises of common stock options
3
190
0
0
Payments on term loans
2,500
2,500
2,500
2,500
Proceeds from financed insurance premium
-
-
0
0
Payment of tax withholding on vesting of shares
1,097
5,588
-
-
Payments on financed insurance premium
0
0
0
67
Other
0
3
4
9
Net cash used in financing activities
-3,594
-7,895
-2,496
-2,558
Net decrease in cash and cash equivalents
1,175
-10,216
3,557
-2,421
Cash and cash equivalents beginning of period
22,822
33,038
95,386
-
Cash and cash equivalents at beginning of period
-
-
-
95,386
Effects of currency translation on cash and cash equivalents
-
-
0
-
Cash and cash equivalents at end of period
-
-
-
29,481
Cash and cash equivalents end of period
23,997
22,822
33,038
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$45,104K
(376.95%↑ Y/Y)
Stock-based compensation
$3,854K
(-61.51%↓ Y/Y)
Accounts receivable,
trade, net
-$2,405K
(-369.62%↓ Y/Y)
Non-cash lease expense
$1,849K
(175.97%↑ Y/Y)
Depreciation
$411K
(-69.69%↓ Y/Y)
Amortization of intangible
assets
$398K
(-71.77%↓ Y/Y)
Net cash provided by
operating activities
$6,348K
(-30.20%↓ Y/Y)
Canceled cashflow
$47,673K
Net decrease in cash
and cash...
$1,175K
(101.85%↑ Y/Y)
Canceled cashflow
$5,173K
Deferred income tax
(benefit) expense
-$42,431K
(-83298.04%↓ Y/Y)
Inventories
$2,757K
(318.81%↑ Y/Y)
Accounts payable
-$1,370K
(-201.10%↓ Y/Y)
Accrued expenses and
other current...
-$755K
(77.72%↑ Y/Y)
Prepaid expenses and
other assets
$246K
(158.16%↑ Y/Y)
Accretion of
available-for-sale investments
$75K
(-75.41%↓ Y/Y)
Sales taxes payable
-$39K
(93.76%↑ Y/Y)
Proceeds from exercises
of common stock...
$3K
(-83.33%↓ Y/Y)
Maturities of
available-for-sale securities
$12,150K
(44.82%↑ Y/Y)
Proceeds from sale of
available-for-sale securities
$2,359K
(34.42%↑ Y/Y)
Net cash used in
financing activities
-$3,594K
(38.77%↑ Y/Y)
Net cash used in
investing activities
-$1,579K
(97.63%↑ Y/Y)
Canceled cashflow
$3K
Canceled cashflow
$14,509K
Payments on term loans
$2,500K
(-50.00%↓ Y/Y)
Payment of tax
withholding on vesting of...
$1,097K
Purchases of
available-for-sale securities
$14,925K
(-76.79%↓ Y/Y)
Purchases of property and
equipment
$1,043K
(-45.62%↓ Y/Y)
Purchase of intangible
assets
$120K
Buy us a coffee
BIOLIFE SOLUTIONS INC (BLFS)
BIOLIFE SOLUTIONS INC (BLFS)